Brimonidine/timolol

Brimonidine/Timolol is a combination ophthalmic medication used for the treatment of glaucoma and ocular hypertension. It consists of two active ingredients:

Brimonidine: An alpha-2 adrenergic receptor agonist that reduces aqueous humor production and increases uveoscleral outflow.
Timolol: A non-selective beta-blocker that decreases intraocular pressure (IOP) by reducing aqueous humor production.

This combination is prescribed for patients who require additional intraocular pressure (IOP) reduction beyond monotherapy.

Mechanism of Action[edit]

The combination of brimonidine and timolol works synergistically to lower intraocular pressure:

Brimonidine (Alpha-2 Agonist)[edit]

Reduces the production of aqueous humor in the ciliary body.
Increases uveoscleral outflow, facilitating the drainage of aqueous humor.
Reduces IOP without significant cardiovascular effects.

Timolol (Beta-Blocker)[edit]

Blocks beta-adrenergic receptors in the ciliary epithelium.
Decreases aqueous humor production, lowering intraocular pressure.
Has no significant effect on aqueous humor outflow.

The dual mechanism provides a greater IOP-lowering effect compared to either drug alone.

Indications[edit]

Brimonidine/Timolol is primarily indicated for:

Glaucoma: Specifically primary open-angle glaucoma, where elevated intraocular pressure can damage the optic nerve.
Ocular hypertension: Increased intraocular pressure without optic nerve damage or visual field loss.

Dosage and Administration[edit]

The typical dosage is one drop in the affected eye(s) twice daily.
It is administered topically as an ophthalmic solution.
Patients should wait at least 5 minutes before using other eye medications.
Contact lenses should be removed before application and reinserted 15 minutes after administration.

Contraindications[edit]

Brimonidine/Timolol should not be used in patients with:

Hypersensitivity to brimonidine, timolol, or excipients in the formulation.
Bronchial asthma or severe chronic obstructive pulmonary disease (COPD).
Sinus bradycardia or second- or third-degree atrioventricular (AV) block.
Cardiogenic shock or overt heart failure.

Side Effects[edit]

Like all medications, Brimonidine/Timolol may cause side effects, including:

Common Side Effects[edit]

Ocular effects:
Eye irritation or redness
Dry eyes
Blurred vision
Burning or stinging sensation

Systemic effects:
Fatigue and drowsiness
Dizziness
Headache
Dry mouth

Serious Adverse Reactions[edit]

Bradycardia (slow heart rate)
Hypotension
Bronchospasm in patients with respiratory disorders
Depression and mood changes
Severe allergic reactions (rare)

Patients experiencing significant side effects should seek medical attention.

Drug Interactions[edit]

Brimonidine/Timolol may interact with various medications:

Beta-blockers (oral or topical) – May cause additive cardiovascular effects.
Antihypertensive drugs – Can enhance hypotensive effects.
CNS depressants (sedatives, alcohol, opioids) – Increased drowsiness.
Monoamine oxidase inhibitors (MAOIs) – Risk of severe hypotension with brimonidine.

Patients should inform their healthcare provider about all medications they are taking.

Special Precautions[edit]

Pregnancy and Breastfeeding[edit]

Pregnancy – Use only if the potential benefit outweighs the risk.
Breastfeeding – Timolol is excreted in breast milk; caution is advised.

Use in Pediatric and Geriatric Populations[edit]

Pediatrics: Not recommended for children under 2 years old due to the risk of central nervous system depression.
Geriatrics: Increased risk of systemic beta-blockade effects.

Storage and Handling[edit]

Store at room temperature (15-25°C).
Keep the bottle tightly closed to prevent contamination.
Avoid touching the dropper tip to any surface.
Discard after the expiration date.

External Links[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!